RT Journal Article
SR Electronic
T1 Categorical and dimensional brain network-based models of trauma-related dissociative subtypes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.29.22274474
DO 10.1101/2022.04.29.22274474
A1 Lebois, Lauren A. M.
A1 Kumar, Poornima
A1 Palermo, Cori A.
A1 Lambros, Ashley M.
A1 O’Connor, Lauren
A1 Wolff, Jonathan D.
A1 Baker, Justin T.
A1 Gruber, Staci A.
A1 Lewis-Schroeder, Nina
A1 Ressler, Kerry J.
A1 Robinson, Matthew A.
A1 Winternitz, Sherry
A1 Nickerson, Lisa D.
A1 Kaufman, Milissa L.
YR 2022
UL http://medrxiv.org/content/early/2022/05/01/2022.04.29.22274474.abstract
AB Background Trauma-related pathological dissociation is a multidimensional and disabling phenomenon that involves disruptions or discontinuities in psychological functioning. Despite its prevalence, personal and societal burden, dissociation remains underappreciated in clinical practice, and it lacks a synthesized neurobiological model that could place it in context with other common psychiatric symptoms. To identify a nuanced neurobiological model of pathological dissociation, we examined the functional connectivity of three core neurocognitive networks as related to the dimensional dissociation subtypes of depersonalization/derealization and partially-dissociated intrusions, and the diagnostic category of a complex dissociation disorder, dissociative identity disorder (DID).Methods Participants were 91 adult women with and without: a history of childhood trauma, current posttraumatic stress disorder (PTSD) and varied levels of pathological dissociation. Participants provided interview and self-report data about pathological dissociation, PTSD symptoms, childhood maltreatment history, and completed a resting-state functional magnetic resonance imaging scan.Results After controlling for age, childhood maltreatment and PTSD symptom severity, we found that pathological dissociation was associated with hyperconnectivity within central executive, default, and salience networks, and decreased connectivity of central executive and salience networks with other areas. Moreover, we isolated unique connectivity markers linked to depersonalization/derealization, to partially-dissociated intrusions, and to DID.Conclusions Our work suggests subtypes of pathological dissociation have robust, discernable, and unique functional connectivity signatures. The neural correlates of dissociation may serve as potential targets for treatment engagement to facilitate recovery from PTSD and pathological dissociation. These results underscore dissociation assessment as crucial in clinical and medical care settings.Competing Interest StatementLAML reports unpaid membership on the Scientific Committee for the International Society for the Study of Trauma and Dissociation (ISSTD), grant support from the National Institute of Mental Health (NIMH), K01 MH118467, and the Julia Kasparian Fund for Neuroscience Research. Dr. Lebois also reports spousal IP payments from Vanderbilt University for technology licensed to Acadia Pharmaceuticals unrelated to the present work. Dr. Ressler has performed scientific consultation for Bioxcel, Bionomics, Acer, Takeda, and Jazz Pharma; serves on Scientific Advisory Boards for Sage and the Brain Research Foundation, and he has received sponsored research support from Takeda, Brainsway and Alto Neuroscience. He receives research funding from the NIH. Dr. Kaufman reports unpaid membership on the Scientific Committee for the ISSTD and grant support from the NIMH, R21 MH112956, R01 MH119227. JTB has received consulting fees from Verily Life Sciences, as well as consulting fees and equity from Mindstrong Health, Inc., unrelated the present work. ISSTD and NIMH were not involved in the analysis or preparation of the manuscript. All other authors have nothing to report.Funding StatementThis study was funded by the Julia Kasparian Fund for Neuroscience Research (LAML, CP, MLK) and the National Institute of Mental Health K01 MH118467 (LAML), R21 MH112956 (MLK), and R01 MH119227 (MLK).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Mass General Brigham gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors